Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
TFX
BUYTeleflex Incorporated · Healthcare · United States · $5.8B · Avg Vol: $57M/d
COMPANY DESCRIPTION
Teleflex Incorporated is a global provider of specialized medical technologies aimed at improving patient health, focusing on product areas such as vascular access, anesthesia, surgical, urology, and interventional cardiology. Its competitive moat is formed by proprietary technologies, robust clinical evidence supporting product efficacy, and established relationships with healthcare providers worldwide. Teleflex is a key innovator in acute care and surgical medical devices.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.8B | 1.7B | 1.7B | 2.0B | -10.6% | 2.1B | 2.3B | 2.4B | 10.0% |
| EPS | 7.74 | 7.58 | 1.49 | -20.30 | -56.1% | — | — | — | — |
| Shares | 46.9M | 47.0M | 46.3M | 44.2M | -5.8% | 44.3M | — | — | — |
| Debt | 1.8B | 1.9B | 1.7B | 2.7B | 14.2% | 2.7B | — | — | — |
| Equity | 4.0B | 4.4B | 4.3B | 3.1B | -8.1% | — | — | — | — |
| Op CF | 342.1M | 510.6M | 635.7M | 340.7M | -0.1% | 316.6M | — | — | — |
| Inv CF | -257.9M | -621.2M | -99.4M | -849.2M | — | — | — | — | — |
| Fin CF | -217.5M | 38.5M | -421.9M | 611.5M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TFX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| TFX | Teleflex Incorporated(you) | $5.8B | 69 | BUY |
| AVTR | Avantor, Inc. | $7.8B | 64 | HOLD |
| ATR | AptarGroup, Inc. | $8.4B | 74 | BUY |
| MMSI | Merit Medical Systems, Inc. | $4.4B | 79 | BUY |
| BAX | Baxter International Inc. | $11.6B | 71 | BUY |
| XRAY | DENTSPLY SIRONA Inc. | $2.6B | 74 | BUY |
| ICUI | ICU Medical, Inc. | $3.9B | 83 | STRONG BUY |
| LMAT | LeMaitre Vascular, Inc. | $2.2B | 76 | BUY |
| NVST | Envista Holdings Corporation | $4.3B | 90 | STRONG BUY |
| SOLV | Solventum Corporation | $13.5B | 80 | BUY |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%